​

Unity Bio (UBX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

UBX Stock Forecast

Unity Bio (UBX) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $4.00, with a high of $4.00 and a low of $4.00. This represents a 312.37% increase from the last price of $0.97.

High: $4 Avg: $4 Low: $4 Last Closed Price: $0.97

UBX Stock Rating

Unity Bio stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (88.89%), 1 Hold (11.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 1 8 Strong Sell Sell Hold Buy Strong Buy

UBX Price Target Upside V Benchmarks

TypeNameUpside
StockUnity Bio312.37%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$4.00$4.00$4.00
Last Closing Price$0.97$0.97$0.97
Upside/Downside312.37%312.37%312.37%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2513---4
Mar, 2512---3
Feb, 2512---3
Jan, 2512---3
Dec, 2411---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 25, 2025Chardan Capital$4.00$1.26217.46%312.37%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 24, 2025H.C. WainwrightBuyBuyhold
Aug 22, 2024Rodman & RenshawBuyinitialise
Apr 16, 2024H.C. WainwrightBuyBuyhold
Nov 16, 2023WedbushOutperformupgrade
Aug 15, 2022CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 $1 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-6.08$-2.70$-1.54----
Avg Forecast$-4.03$-2.83$-1.37$-1.01$-0.96$-0.47$0.22
High Forecast$-4.03$-2.51$-1.33$-0.61$-0.85$0.54$0.22
Low Forecast$-4.03$-3.15$-1.41$-1.40$-1.06$-1.48$0.22
Surprise %50.87%-4.59%12.41%----

Revenue Forecast

$0 $18M $36M $54M $72M $90M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$236.00K------
Avg Forecast$218.00K--$500.00K$8.25M$32.35M$86.10M
High Forecast$218.00K--$500.00K$8.25M$32.35M$86.10M
Low Forecast$218.00K--$500.00K$8.25M$32.35M$86.10M
Surprise %8.26%------

Net Income Forecast

$-60M $-46M $-32M $-18M $-4M $10M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-57.75M$-39.86M$-25.99M----
Avg Forecast$-59.60M$-39.86M$-20.26M$-14.85M$-14.12M$-10.97M$3.18M
High Forecast$-59.60M$-37.08M$-19.70M$-8.97M$-12.52M$7.94M$3.18M
Low Forecast$-59.60M$-46.47M$-20.81M$-20.73M$-15.71M$-21.82M$3.18M
Surprise %-3.11%-28.31%----

UBX Forecast FAQ

Is Unity Bio stock a buy?

Unity Bio stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Unity Bio is a favorable investment for most analysts.

What is Unity Bio's price target?

Unity Bio's price target, set by 9 Wall Street analysts, averages $4 over the next 12 months. The price target range spans from $4 at the low end to $4 at the high end, suggesting a potential 312.37% change from the previous closing price of $0.97.

How does Unity Bio stock forecast compare to its benchmarks?

Unity Bio's stock forecast shows a 312.37% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for Unity Bio over the past three months?

  • April 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Unity Bio’s EPS forecast?

Unity Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.01, marking a -34.42% decrease from the reported $-1.54 in 2024. Estimates for the following years are $-0.96 in 2026, $-0.47 in 2027, and $0.22 in 2028.

What is Unity Bio’s revenue forecast?

Unity Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $500K, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $8.25M, followed by $32.35M for 2027, and $86.1M for 2028.

What is Unity Bio’s net income forecast?

Unity Bio's net income forecast for the fiscal year ending in December 2025 stands at $-14.854M, representing a -42.85% decrease from the reported $-25.99M in 2024. Projections indicate $-14.116M in 2026, $-10.97M in 2027, and $3.18M in 2028.